Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Patients who have a current or past diagnosis of certain medical conditions may not be candidates for semaglutide, including those diagnosed with: Pancreatitis Thyroid cancer Type I diabetes Severe episodes of low blood sugar Gallbladder issues Multiple endocrine neoplasia syndrome type 2 (MEN2) It is important to note that a patient with one or more of these conditions may still qualify for a semaglutide weight loss program
If you have pre-existing gastrointestinal conditions such as inflammatory bowel disease, gastroparesis, or a history of bowel obstruction, discuss these with your clinician before starting Wegovy
Hernexeos approval expanded to include treatment-nave HER2-mutant NSCLC
A study published in 2025 looked at 150 people diagnosed with IBD and obesity who took semaglutide for weight loss
US$ 21.08
US$ 29.00
US$ 28.98
